Crossmark

Discovery and characterization of a novel telomerase alternative splicing isoform that protects lung cancer cells from chemotherapy induced cell death

Crossref DOI link: https://doi.org/10.1038/s41598-025-90639-3

Published Online: 2025-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Jeongjin J.

Ahn, Alexander

Ying, Jeffrey Y.

Ludlow, Andrew T.
Funding

Funding for this research was provided by:

National Cancer Institute (5R00CA197672-04)

University of Michigan’s School of Kinesiology Marie Hartwig Research Fund

University of Michigan’s Rogel Cancer Center, Cancer Genetics Small Pilot grant
License Information

Text and Data Mining valid from 2025-02-25

Version of Record valid from 2025-02-25
More Information

Article History

Received: 21 October 2024

Accepted: 14 February 2025

First Online: 25 February 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below